EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics

Jie Chen, Zixuan Bu, Qimin Zhan

Science Bulletin · 2026-04 · 71 (7) · 1812-1830

DOI: 10.1016/j.scib.2026.02.048 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Science Bulletin, 2026-04. Verfasst von Jie Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Canc…. Hauptthemen laut MEDLINE: Neoplasms, Focal Adhesion Protein-Tyrosine Kinases, Antineoplastic Agents, Protein Kinase Inhibitors. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 287 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Focal adhesion kinase (FAK) is a key cytoplasmic tyrosine kinase that transmits signals from integrins and growth factors to control cell migration, metastasis, growth and survival. FAK can modulate prominent oncogenic pathways, such as the phosphatidylinositol 3 kinase/protein kinase B (PI3K/AKT) and Rat Sarcoma virus/extracellular signal-regulated kinase (Ras/ERK) pathway, through autophosphorylation at Y397 and subsequent conformational activation. Notably, FAK is overexpressed and activated in many solid tumors. Its expression levels are correlated with tumor stage, lymph node metastasis, and poor prognosis. Moreover, FAK promotes tumor malignancy by inducing epithelial-mesenchymal transition (EMT), chemoresistance, and stemness properties. However, targeting FAK is considerably challenging owing to signal complexity. To date, only eight small-molecule FAK inhibitors have reached the clinical trial stage, mainly in combination with chemotherapy, targeted therapy, or immunotherapy. Recent advances, such as proteolysis-targeting chimeras (PROTACs) degraders, protein-protein interaction (PPI) blockers, allosteric inhibitors, and natural products, offer promising opportunities to overcome current therapeutic challenges. The present review provides a comprehensive discussion of FAK, ranging from its structure and regulatory mechanisms to its central role in tumor malignancy and the current status of inhibitor development, aiming to inform future translational efforts in solid tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsFocal Adhesion Protein-Tyrosine KinasesAntineoplastic AgentsProtein Kinase InhibitorsHumansAnimalsSignal TransductionMolecular Targeted TherapyEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

Combination therapyFocal adhesion kinaseInhibitorsMolecular mechanismsSolid tumors

Substanzen

Focal Adhesion Protein-Tyrosine KinasesAntineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China; Peking University Inte…
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Laboratory of Molecular Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Chen, J., Bu, Z., & Zhan, Q. (2026). Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics. Science Bulletin, 71(7), 1812-1830. https://doi.org/10.1016/j.scib.2026.02.048

Vancouver

Chen J, Bu Z, Zhan Q. Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics. Science Bulletin. 2026;71(7):1812-1830. doi:10.1016/j.scib.2026.02.048

BibTeX
@article{Chen2026,
  author = {Chen, Jie and Bu, Zixuan and Zhan, Qimin},
  title = {Targeting focal adhesion kinase: from molecular mechanisms to next-generation cancer therapeutics},
  journal = {Science Bulletin},
  year = {2026},
  volume = {71},
  number = {7},
  pages = {1812--1830},
  doi = {10.1016/j.scib.2026.02.048}
}
Kostenlos starten →